Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
Rosacea: new and emerging treatments
Farah A Moustafa1, Laura F Sandoval, Steven R Feldman
1Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071, USA.
New treatments for rosacea, a chronic skin condition, show promise. While some therapies like brimonidine tartrate and topical ivermectin are effective, more research is needed to confirm their long-term safety and efficacy.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Rosacea is a chronic inflammatory skin condition impacting patient quality of life.
- Understanding rosacea pathogenesis is crucial for effective management.
- Current treatment options have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review key aspects of rosacea pathogenesis.
- To evaluate the role of emerging treatments in rosacea management.
- To identify gaps in evidence for new rosacea therapies.
Main Methods:
- Literature review of pathogenesis and treatment of rosacea.
- Analysis of randomized controlled trials (RCTs) and case reports for new treatments.
- Assessment of emerging therapies including brimonidine tartrate, oxymetazoline, and ivermectin.
Main Results:
- Brimonidine tartrate is approved for erythematotelangiectatic rosacea.
- Topical oxymetazoline shows potential for erythematotelangiectatic rosacea, with ongoing RCTs.
- Topical and oral ivermectin demonstrate benefit for papulopustular rosacea, with topical ivermectin 1% cream studied in RCTs.
Conclusions:
- Emerging treatments for rosacea offer promising therapeutic avenues.
- High-quality RCTs are lacking for many new rosacea drugs.
- Further research is essential to establish long-term safety and efficacy of novel interventions.
Related Concept Videos
Acne Infection
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antidepressant Drugs: MAOIs and Other Agents
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treatment Resistent Cancers
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

